nateglinide inn trade name starlix drug treatment type diabetes nateglinide developed ajinomoto japanese company sold swiss pharmaceutical company novartis nateglinide belongs meglitinide class blood glucoselowering drugs nateglinide lowers blood glucose stimulating release insulin pancreas achieves closing atpdependent potassium channels membrane β cells depolarizes β cells causes voltagegated calcium channels open resulting calcium influx induces fusion insulincontaining vesicles cell membrane insulin secretion occurs nateglinide contraindicated patients study funded novo nordisk us distributor repaglinide compared product nateglinide randomized parallelgroup openlabel multicenter clinical concluded two similar repaglinide monotherapy significantly effective nateglinide monotherapy reducing fpg values weeks therapy nateglinide delivered mg mg tablet form httpsenwikipediaorgwikinateglinide